Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here?
Ontology highlight
ABSTRACT: Traumatic brain injury (TBI) is the leading cause of death and disability in young adults. Survivors of TBI frequently suffer from long-term personality changes and deficits in cognitive and motor performance, urgently calling for novel pharmacological treatment options. To date, all clinical trials evaluating neuroprotective compounds have failed in demonstrating clinical efficacy in cohorts of severely injured TBI patients. The purpose of the present review is to describe the utility of animal models of TBI for preclinical evaluation of pharmacological compounds. No single animal model can adequately mimic all aspects of human TBI owing to the heterogeneity of clinical TBI. To successfully develop compounds for clinical TBI, a thorough evaluation in several TBI models and injury severiti
SUBMITTER: Marklund N
PROVIDER: S-EPMC3229758 | biostudies-literature | 2011 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA